Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fabry

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|January 1, 1995
Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patientT Efferth, U Fabry, P Glatte, et al.
Pediatric Research|April 1, 1985
Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanismU Fabry, D Körholz, H Jürgens, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 24, 2001
[An unusual etiology of erythrocytosis in a 23-year-old primiparous woman in the 22nd week of pregnancy]O Maywald, O Galm, U Fabry, et al.
Klinische Padiatrie|July 1, 1986
[Significance of immune complexes in children with severe hemophilia A in substitution treatment with factor VIII concentrates]D Körholz, V Wahn, R von Kries, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Modified pharmacokinetics of I-asparaginase from E coli by formation of specific antibodies to I-Asparaginase of different immunoglobulin classes in children with acute lymphocytic leukemiaV Wahn, U Fabry, D Körholz, et al.
Nuclear Medicine Communications|December 23, 1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]U Cremerius, U Fabry, U Kröll, et al.
Nuklearmedizin. Nuclear Medicine|May 26, 2001
Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Arzneimittel-Forschung|February 1, 1996
Detection of apoptosis in KG-1a leukemic cells treated with investigational drugsT Efferth, G Rücker, M Falkenberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1995
Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patientR R Reinert, N Schnitzler, G Haase, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|January 1, 1995
Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patientT Efferth, U Fabry, P Glatte, et al.
Pediatric Research|April 1, 1985
Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanismU Fabry, D Körholz, H Jürgens, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 24, 2001
[An unusual etiology of erythrocytosis in a 23-year-old primiparous woman in the 22nd week of pregnancy]O Maywald, O Galm, U Fabry, et al.
Klinische Padiatrie|July 1, 1986
[Significance of immune complexes in children with severe hemophilia A in substitution treatment with factor VIII concentrates]D Körholz, V Wahn, R von Kries, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Modified pharmacokinetics of I-asparaginase from E coli by formation of specific antibodies to I-Asparaginase of different immunoglobulin classes in children with acute lymphocytic leukemiaV Wahn, U Fabry, D Körholz, et al.
Nuclear Medicine Communications|December 23, 1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Nuklearmedizin. Nuclear Medicine|February 13, 1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]U Cremerius, U Fabry, U Kröll, et al.
Nuklearmedizin. Nuclear Medicine|May 26, 2001
Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphomaU Cremerius, U Fabry, J Neuerburg, et al.
Arzneimittel-Forschung|February 1, 1996
Detection of apoptosis in KG-1a leukemic cells treated with investigational drugsT Efferth, G Rücker, M Falkenberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1995
Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patientR R Reinert, N Schnitzler, G Haase, et al.
Pageof 3